Pharmacokinetics of single and multiple oral doses of arbidol in healthy Chinese volunteers.

@article{Sun2013PharmacokineticsOS,
  title={Pharmacokinetics of single and multiple oral doses of arbidol in healthy Chinese volunteers.},
  author={Yaxin Sun and Xiaojing He and Feng Qiu and Xu Chao Zhu and Mingming Zhao and Jesse Li-Ling and Xianying Su and Limei Zhao},
  journal={International journal of clinical pharmacology and therapeutics},
  year={2013},
  volume={51 5},
  pages={423-32}
}
BACKGROUND Arbidol is licensed in Russia and China for prophylaxis and treatment of influenza A and B. This study was to assess the pharmacokinetics of single and multiple doses of arbidol in healthy Chinese volunteers. METHODS This was a single-center, open-label, two-phase study conducted in 12 subjects. In single-dose phase, subjects were randomized to receive single doses of 0.2, 0.4 and 0.8 g of arbidol in a crossover design with a 7-day washout period between administration. In the… CONTINUE READING